ベータ
治験レーダーAI

糖尿病、末期腎疾患（ESRD）の治験を表示しています。

健康状態や治療法を理解し、近くの治験を探すお手伝いができます。
私たちの検索ツールは英語のみをサポートしています。他の言語で検索と議論するには、上の治験レーダーを使用するか、以下の疾患と場所のフィルターを選択してください。
63 結果
上位 50 件を表示
 
疾患名
糖尿病、末期腎疾患（ESRD）
×
 
相・段階
第IV相・フェーズ4
×
 
試験タイトル
状況
Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD NCT03526536
中止
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia) NCT00567489
完了結果公開
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis (GUARD-1) NCT07017270
募集準備中
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography NCT00209417
中止結果公開
Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes NCT01617824
完了
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency NCT00911625
完了結果公開
Empagliflozin in Renal Transplant Recipients (EMPA-RenalTx) NCT03157414
完了
Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients NCT02009514
完了
Liraglutide Treatment to Patients With Severe Renal Insufficiency NCT01394341
完了
Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy NCT00295555
完了
1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy NCT00748072
完了結果公開
Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation NCT00936663
中止結果公開
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure NCT00438503
完了
Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure. (DINAMO) NCT01122979
完了
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes NCT06054035
募集中
DIALYSIS-TIR Study NCT06042153
実施中／登録終了
Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes NCT02964585
完了結果公開
Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients NCT01448174
完了
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography NCT00950079
状況不明
Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy NCT01722513
状況不明
Linagliptin's Effect on CD34+ Stem Cells NCT02467478
完了結果公開
Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment (TRENT) NCT05552859
中止結果公開
Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes (TRACK-D) NCT00786136
完了
Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes NCT02808351
完了
Dapagliflozin Treatment in Type 2 Diabetes NCT04620590
完了
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus (PRODAPA-CKD) NCT06281899
状況不明
Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment (PLAUDIT) NCT01035320
完了
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus NCT05705271
完了
Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease NCT02539160
完了結果公開
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients (RECARE) NCT00782639
中止結果公開
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. (@HOME) NCT06374043
完了
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes. (FineCaRe) NCT07026539
募集中
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease (RAiSiN) NCT06727409
募集中
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease (GLOW-CKD) NCT07116928
募集準備中
REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations NCT04243850
撤回
Glargine Versus NPH in Patients With Chronic Kidney Disease NCT02451917
完了結果公開
Chronotherapy with Low-dose Aspirin for Primary Prevention (CARING) NCT00725127
実施中／登録終了
Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD) NCT06252051
完了
2型糖尿病および慢性腎臓病患者における血管硬化度と心腎バイオマーカーに対するフィネレノンの影響（FIVE-STAR試験） NCT05887817
実施中／登録終了
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus NCT03774394
完了結果公開
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial (Optimize@Home) NCT06094920
完了
Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD NCT04215445
状況不明
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record (APPLE TREE) NCT06642272
募集中
Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography NCT00335101
撤回
Renal Denervation in Diabetic Nephropathy (DERENEDIAB) NCT01588795
完了
Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients (PAISPK) NCT03470961
状況不明
RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD NCT03789695
状況不明
SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI) NCT05037695
状況不明
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases NCT07187713
募集中
POST-CABGDM: Empagliflozin in Perioperative CABG NCT04523064
完了